-+ 0.00%
-+ 0.00%
-+ 0.00%

EQS-NEWS: IMMUNIC REPORTS NEW, POSITIVE LONG-TERM OPEN-LABEL EXTENSION DATA FROM PHASE 2 EMPHASIS TRIAL OF VIDOFLUDIMUS CALCIUM IN RELAPSING-REMITTING MULTIPLE SCLEROSIS

Reuters·06/24/2025 10:30:11

Please log in to view news